Sanofi-Aventis Australia Pty Ltd - proposed acquisition of Ostelin brands from Reckitt Benckiser Australia Pty Ltd

Acquirer(s)

  • Sanofi-Aventis Australia Pty Ltd

Target(s)

  • Ostelin brands from Reckitt Benckiser Australia Pty Ltd

Summary

Sanofi-Aventis Australia Pty Ltd proposed to acquire Ostelin brands from Reckitt Benckiser Australia Pty Ltd.

Market definition

The ACCC considered the competitive effects of the proposed acquisition in the context of:
- the national market for the wholesale supply of calcium supplements; and
- the national market for the wholesale supply of vitamin D supplements.
However, the ACCC recognised that the results of the analysis would have been unchanged, regardless of the market definition adopted.

Competition analysis

The ACCC formed the view that the proposed acquisition was unlikely to substantially lessen competition in the relevant markets. Factors informing this conclusion included:
- the merged entity would continue to be constrained by existing and potential competitors;
- barriers to entry and expansion are low; and
- the relevant markets are dynamic.

Timeline

DateEvent
03/07/2009ACCC commenced review under the Merger Review Process Guidelines.
10/07/2009Closing date for submissions from interested parties.
13/07/2009ACCC announced it would not oppose the proposed acquisition.